Financial Summary (All financials)
| In millions of CNY, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 2,959.3 | 1,352.2 | 670.5 |
| Revenue growth | 118.9% | 101.7% | |
| Cost of goods sold | 1,405.4 | 594.4 | 358.2 |
| Gross profit | 1,553.9 | 757.8 | 312.3 |
| Gross margin | 52.5% | 56.0% | 46.6% |
| Sales and marketing | 1,634.7 | 734.8 | 766.5 |
| Research and development | 619.6 | 329.8 | 351.0 |
| General and administrative | 690.3 | 296.2 | 253.3 |
| EBITA | -1,375.0 | -591.4 | -1,047.3 |
| EBITA margin | -46.5% | -43.7% | -156.2% |
| Amortization of intangibles | 15.7 | 11.5 | 11.2 |
| EBIT | -1,390.7 | -602.9 | -1,058.5 |
| EBIT margin | -47.0% | -44.6% | -157.9% |
| Pre-tax income | -1,293.4 | -516.5 | -1,004.2 |
| Income taxes | 5.4 | 1.1 | 0.0 |
| Net income | -1,469.5 | -1,198.3 | -1,431.0 |
| Net margin | -49.7% | -88.6% | -213.4% |
| |
| Diluted EPS | ($6.12) | ($18.36) | ($22.99) |
| Shares outstanding (diluted) | 240.2 | 65.3 | 62.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|